NSAIDs in the prevention of dementia - A Cache-22?

被引：5

作者：

Scharf, Jeremiah M. ^{[1
]}

Daffner, Kirk R. ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Div Cognit & Behav Neurol, Dept Neurol, Boston, MA 02115 USA

来源：

NEUROLOGY | 2007年 / 69卷 / 03期

关键词：

D O I：

10.1212/01.wnl.0000271092.02245.6d

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：235 / 236

页数：2

共 12 条

[1] Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial [J].

Aisen, PS ;

Schafer, KA ;

Grundman, M ;

Pfeiffer, E ;

Sano, M ;

Davis, KL ;

Farlow, MR ;

Jin, S ;

Thomas, RG ;

Thal, LJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (21) :2819-2826

[2] Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer's disease? [J].

Breitner, JCS ;

Zandi, PP .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (21) :1567-1568

[3] NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo [J].

Eriksen, JL ;

Sagi, SA ;

Smith, TE ;

Weggen, S ;

Das, P ;

McLendon, DC ;

Ozols, VV ;

Jessing, KW ;

Zavitz, KH ;

Koo, EH ;

Golde, TE .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) :440-449

[4] Does NSAID use modify cognitive trajectories in the elderly? The Cache county study [J].

Hayden, K. M. ;

Zandi, P. P. ;

Khachaturian, A. S. ;

Szekely, C. A. ;

Fotuhi, M. ;

Norton, M. C. ;

Tschanz, J. T. ;

Pieper, C. F. ;

Corcoran, C. ;

Lyketsos, C. G. ;

Breitner, J. C. S. ;

Welsh-Bohmer, K. A. .

NEUROLOGY, 2007, 69 (03) :275-282

[5]

Lyketsos CG, 2007, NEUROLOGY, V68, P1800

[6] Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's disease Anti-inflammatory Prevention Trial (ADAPT) [J].

Martin, Barbara K. ;

Breitner, John C. S. ;

Evans, Denis ;

Lyketsos, Constantine G. ;

Meinert, Curtis L. .

PLOS CLINICAL TRIALS, 2006, 1 (07)

[7]

Maxwell CJ, 1999, CAN MED ASSOC J, V161, P501

[8] Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review [J].

Szekely, CA ;

Thorne, JE ;

Zandi, PP ;

Ek, M ;

Messias, E ;

Breitner, JCS ;

Goodman, SN .

NEUROEPIDEMIOLOGY, 2004, 23 (04) :159-169

[9] A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment [J].

Thal, LJ ;

Ferris, SH ;

Kirby, L ;

Block, GA ;

Lines, CR ;

Yuen, E ;

Assaid, C ;

Nessly, ML ;

Norman, BA ;

Baranak, CC ;

Reines, SA .

NEUROPSYCHOPHARMACOLOGY, 2005, 30 (06) :1204-1215

[10] A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity [J].

Weggen, S ;

Eriksen, JL ;

Das, P ;

Sagi, SA ;

Wang, R ;

Pietrzik, CU ;

Findlay, KA ;

Smith, TE ;

Murphy, MP ;

Butler, T ;

Kang, DE ;

Marquez-Sterling, N ;

Golde, TE ;

Koo, EH .

NATURE, 2001, 414 (6860) :212-216

← 1 2 →